You have read all your free articles, to continue reading subscribe to read the rest of this content.
Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for expanded use of Tresiba®(insulin degludec) in children and adolescents aged 1-17 years with diabetes. Once the European Commission approves the label expansion, physicians in the Already a subscriber Login You have…
Nordic Nanovector has enrolled the final two patients into the second safety cohort of its Phase 1 Archer-1 (LYMRIT 37-07) trial investigating safety and preliminary efficacy of Betalutin (177Lu lilotomab satetraxetan) in combination with rituximab in 2nd-line follicular lymphoma (2L FL). The dosAlready a subscriber Login You have read all…
Aqilion has announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has approved the company’s Phase 1 clinical trial with its drug candidate AQ280. Aqilion applied to conduct a Phase I safety study in 64 healthy volunteers with the drug candidate AQ280 within thAlready a subscriber…
AlzeCure Pharma has presented new study results at at the Alzheimer's Association International Conference (AAIC) 2021. The new results demonstrate how their clinical candidate drug ACD856 for Alzheimer's disease binds to neurotrophin receptors, so-called Trk receptors. The studies show that ACD8Already a subscriber Login You have read all your free…
